Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunocytochemical localization of ubiquitin in inclusion body myositis allows its light-microscopic distinction from polymyositis.

× No keyword cloud information.

9 in total

1. Glucocorticoid-sensitive hereditary inclusion body myositis.

Authors: M Naumann; H Reichmann; H H Goebel; C Moll; K V Toyka
Journal: J Neurol Date: 1996-02 Impact factor: 4.849

2. The group 2 metabotropic glutamate receptor agonist LY379268 rescues neuronal, neurochemical and motor abnormalities in R6/2 Huntington's disease mice.

Authors: A Reiner; D C Lafferty; H B Wang; N Del Mar; Y P Deng
Journal: Neurobiol Dis Date: 2012-03-27 Impact factor: 5.996

Review 3. Inclusion body myositis.

Authors: M J Garlepp; F L Mastaglia
Journal: J Neurol Neurosurg Psychiatry Date: 1996-03 Impact factor: 10.154

4. Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau.

Authors: V Askanas; W K Engel; M Bilak; R B Alvarez; D J Selkoe
Journal: Am J Pathol Date: 1994-01 Impact factor: 4.307

5. Strong immunoreactivity of alpha 1-antichymotrypsin co-localizes with beta-amyloid protein and ubiquitin in vacuolated muscle fibers of inclusion-body myositis.

Authors: M Bilak; V Askanas; W K Engel
Journal: Acta Neuropathol Date: 1993 Impact factor: 17.088

6. Inclusion body myositis: clinical and histopathological features of 36 patients.

Authors: S Beyenburg; S Zierz; F Jerusalem
Journal: Clin Investig Date: 1993-05

Review 7. Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer's and Parkinson's disease brains.

Authors: Valerie Askanas; W King Engel
Journal: Acta Neuropathol Date: 2008-10-31 Impact factor: 17.088

Review 8. Newest pathogenetic considerations in inclusion-body myositis: possible role of amyloid-beta, cholesterol, relation to aging and to Alzheimer's disease.

Authors: Valerie Askanas; W King Engel
Journal: Curr Rheumatol Rep Date: 2002-10 Impact factor: 4.592

9. CAG repeat lengths > or =335 attenuate the phenotype in the R6/2 Huntington's disease transgenic mouse.

Authors: I Dragatsis; D Goldowitz; N Del Mar; Y P Deng; C A Meade; Li Liu; Z Sun; P Dietrich; J Yue; A Reiner
Journal: Neurobiol Dis Date: 2008-11-06 Impact factor: 5.996

9 in total